The results (Figure 2) revealed that the mRNA expression of RIMKLB was significantly increased in the mucinous adenocarcinoma (p < 0.001), rectum (p < 0.001), lymph node stage (N0) (p = 0.0485), advanced stages (III/IV) (p < 0.001), and with tumor (p < 0.001). Here, RIMKLB is linked to neoplasm.